Gramm Jefferson

Director Gramm Jefferson buys 1,250,000 shares of IVFH at $1.60 for $2,000,000; holdings rise 25.3% to 6.19M shares.

Gramm Jefferson, a Director, purchased 1,250,000 shares at $1.60 on 2024-12-04, increasing his stake by 25.3% to 6,193,349 shares—a substantial personal capital commitment of $2,000,000. This is his fourth open-market purchase at IVFH; his prior three buys at this ticker all showed positive 90-day returns (ranging from +14.4% to +24.2%), and across his full cross-ticker track record, all 3 prior buys posted positive 90-day returns with a 100% win rate. The current price of $1.90 sits at the 52-week high, and the stock is up +21.8% over the past 30 days and +39.7% over 90 days—price momentum has already materialized since the December 4 entry. However, the company's fundamentals present tension: annual revenue declined 9.8% year-over-year, it was unprofitable over the most recent full fiscal year, and the P/E of 95 reflects a stretched valuation even at current depressed absolute prices. The timing of this buy—following prior successful accumulations and during a period of strong price appreciation—and the significant size of the position merit scrutiny of whether the director's historical pattern remains reliable amid deteriorating operational trends.

Director Gramm Jefferson purchased 350,000 shares of IVFH at $1.20 on 2024-07-21; holding now 4,943,349 shares. Cluster buy with 2 others in 14 days.

Gramm Jefferson, a Director, purchased 350,000 shares at $1.20 on 2024-07-21, increasing his post-transaction holdings to 4,943,349 shares (+7.6% vs pre-transaction holdings). This purchase is part of a cluster pattern, with 2 other insiders also buying within the past 14 days. The timing coincides with positive recent price action (30-day change: +9.8%; 90-day change: +39.6%), though the stock trades at $1.34, which is 4.3% below its 52-week high. The company's fundamentals show declining revenue (annual growth of -9.8%) and full-year net profitability concerns, though the latest quarter posted net income of $1,425,874.00 on revenue of $15,730,113.00. The multi-insider buying activity in a declining-revenue environment warrants observation of whether this reflects contrarian conviction or routine portfolio positioning.

Director Gramm Jefferson purchased 1,108,349 shares at $1.20 for $1,330,018.80, raising stake to 4,593,349 shares (+31.8%).

Gramm Jefferson, a director of Innovative Food Holdings, executed 2 separate purchases totaling 1,108,349 shares for $1,330,018.80 on 2024-07-17, increasing his holdings by 31.8% to 4,593,349 shares. The company is currently trading at $1.22, near its 52-week high of $1.27, following a +29.8% run over the past 90 days. However, the underlying business faces headwinds: annual revenue declined 9.8% year-over-year, the latest quarter posted revenue of $15,730,113.00 with only $1,425,874.00 in net income, and the company recorded negative net income over its most recent full fiscal year. The substantial accumulation by a board member at prices close to recent highs, combined with deteriorating fundamentals and unprofitability on an annual basis, merits examination of whether this purchase reflects conviction in a turnaround or reflects other considerations.